Literature DB >> 3300307

Massive insulin resistance apparently due to rapid clearance of circulating insulin.

G Williams, J C Pickup, H Keen.   

Abstract

A 23-year-old insulin-dependent diabetic woman demonstrated increasing resistance to insulin administered by all routes, eventually requiring up to 20,000 units per day intravenously. Therapeutic trials of human and chemically modified insulin and of aprotinin were unsuccessful. Inappropriately low plasma free insulin levels (less than 60 mU/liter) during administration of extremely high insulin dosages (300 to 10,000 units per day) suggested that resistance was caused by rapid clearance of circulating insulin. There were several short periods of normal insulin sensitivity with hyperinsulinemia (more than 300 mU/liter) persisting long after intravenous insulin withdrawal, suggesting reentry to the circulation of intact, previously sequestered insulin. For four years, she has been treated with ambulatory continuous intravenous insulin infusion, which has been complicated by septicemia and central venous thrombosis. Her condition remains poorly controlled with documented intravenous insulin requirements of 2 to 20 units/hour.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300307     DOI: 10.1016/0002-9343(87)90234-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  'Brittle' diabetes.

Authors:  G Williams; G V Gill; J C Pickup
Journal:  BMJ       Date:  1991-09-21

2.  "Brittle" diabetes.

Authors:  S A Amiel
Journal:  BMJ       Date:  1991-08-03

3.  Antibody-Mediated Inhibition of Insulin-Degrading Enzyme Improves Insulin Activity in a Diabetic Mouse Model.

Authors:  Ofir Fursht; Mirit Liran; Yuval Nash; Vijay Krishna Medala; Dor Ini; Tabitha Grace Royal; Guy Goldsmith; Limor Nahary; Itai Benhar; Dan Frenkel
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561

4.  Extreme insulin resistance in a patient with diabetes ketoacidosis and acute myocardial infarction.

Authors:  Yin H Oo; Jocelyne G Karam; Christine A Resta
Journal:  Case Rep Endocrinol       Date:  2013-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.